Cargando…

Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease: A Long Term Study

OBJECTIVE: Interstitial lung disease (ILD) frequently complicates systemic sclerosis (SSc). Cyclophosphamide (CYC) is a promising immunosuppressive therapy for SSc-related ILD. Our objective was to investigate the effectiveness of an intravenous CYC (iv CYC) pulse regime in SSc-related ILD during tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simeón-Aznar, C.P, Fonollosa-Plá, V, Tolosa-Vilella, C, Selva-O´Callaghan, A, Solans-Laqué, R, Palliza, E, Muñoz, X, Vilardell-Tarrés, M
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606648/ https://www.ncbi.nlm.nih.gov/pubmed/19340324 http://dx.doi.org/10.2174/1874306400802010039

Ejemplares similares

Quantitative videocapillaroscopy correlates with functional respiratory parameters: a clue for vasculopathy as a pathogenic mechanism for lung injury in systemic sclerosis
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2018)

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

P03-014 - Biological therapy for autoinflammatory disorders
por: Rivas, S Bujan, et al.
Publicado: (2013)

Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

P02-022 - Atypical cryopirin associated periodic syndrome
por: Rivas, S Bujan, et al.
Publicado: (2013)

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
por: van den Hombergh, W. M. T., et al.
Publicado: (2018)

DEXAMETHASONE–CYCLOPHOSPHAMIDE PULSE THERAPY IN PROGRESSIVE SYSTEMIC SCLEROSIS
por: Viswanath, Vishalakshi, et al.
Publicado: (2010)

Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death
por: Simeón-Aznar, C.P., et al.
Publicado: (2015)

Scleroderma renal crisis during intravenous cyclophosphamide pulse therapy for complicated interstitial lung disease was successfully treated with angiotensin converting enzyme inhibitor and plasma exchange
por: Nagamura, Norihiro, et al.
Publicado: (2016)

Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis
por: Labrador-Horrillo, Moises, et al.
Publicado: (2014)

Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis
por: La-Crette, Jonathan, et al.
Publicado: (2017)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center
por: Guillén-Del Castillo, Alfredo, et al.
Publicado: (2017)

PReS-FINAL-2172: Efficacy of corticosteroids and intravenous cyclophosphamide for patients with juvenile systemic sclerosis
por: Kikuchi, M, et al.
Publicado: (2013)

Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders
por: Kuwana, Masataka, et al.
Publicado: (2021)

Intravenous Cyclophosphamide Therapy in Adults with Henoch-Schönlein Purpura
por: Shin, Jae Il, et al.
Publicado: (2008)

Water Intoxication Following Low-Dose Intravenous Cyclophosphamide
por: Koo, Tai Yeon, et al.
Publicado: (2007)

Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient
por: Kanai, Hiroaki, et al.
Publicado: (2013)

Dexamethasone- cyclophosphamide pulse in collagen vascular diseases: An observation
por: Das, Sudip, et al.
Publicado: (2011)

Cyclophosphamide for the treatment of Acute Exacerbation of Interstitial Lung Disease: A Review of the Literature
por: Innabi, Ayoub, et al.
Publicado: (2021)

Diseño de prótesis y aparatos de ortodoncia /
por: Fonollosa Pla, Josep Ma
Publicado: (2004)

Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review
por: Fritzler, Marvin J., et al.
Publicado: (2023)

Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: A case-control study
por: Baba, Sayumi, et al.
Publicado: (2011)

Therapeutic efficacy of combined glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis for skin sclerosis in diffuse systemic sclerosis
por: Suga, Kensuke, et al.
Publicado: (2020)

Interstitial pneumonia induced by cyclophosphamide: A case report and review of the literature
por: Qian, Panpan, et al.
Publicado: (2019)

Proliferation of Interstitial Cells in the Cyclophosphamide-Induced Cystitis and the Preventive Effect of Imatinib
por: Sancho, Maria, et al.
Publicado: (2017)

Oral versus intravenous administration of cyclophosphamide: a case report
por: Wu, Kenneth S, et al.
Publicado: (2008)

Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy
por: Venkatesh, Pradeep, et al.
Publicado: (2015)

Prótesis removible de resina /
por: Fonollosa Pla, Josep Maria, 1960-
Publicado: (2004)

Efficacy of Intravenous Cyclophosphamide Pulse Therapy for P-Glycoprotein-expressing B Cell-associated Active True Renal Lupus Vasculitis in Lupus Nephritis
por: Kawabe, Akio, et al.
Publicado: (2017)

Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases
por: Nucera, Valeria, et al.
Publicado: (2021)

The NLRP3 Inflammasome Inhibitor Dapansutrile Attenuates Cyclophosphamide-Induced Interstitial Cystitis
por: Kiran, Sonia, et al.
Publicado: (2022)

Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
por: Umeda, Akira, et al.
Publicado: (2014)

Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis
por: Vachvanichsanong, Prayong, et al.
Publicado: (2012)

Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still's Disease
por: Tsuji, Yoshika, et al.
Publicado: (2015)

Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
por: Kersten, Brigit E, et al.
Publicado: (2020)

Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
por: Kersten, Brigit E, et al.
Publicado: (2020)

Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide
por: Ciaffi, Jacopo, et al.
Publicado: (2022)

Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children
por: Al Salloum, Abdullah A.
Publicado: (2004)

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial
por: Cobo, E, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nt3chjn46vfvlad9cod6p9t8ne